A Randomized, Double-Blind, Parallel-group, Placebo-Controlled comparison of omeprazole 20 mg once daily, omeprazole 10 mg, and placebo in adult patients (18 – 80 years of age) with healed endoscopically-diagnosed gastro esophageal reflux disease (GERD) for 1 year or until relapse.

Study identifier:I-653-B

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Double-Blind, Parallel-group, Placebo-Controlled comparison of omeprazole 20 mg once daily, omeprazole 10 mg, and placebo in adult patients (18 – 80 years of age) with healed endoscopically-diagnosed gastro esophageal reflux disease (GERD) for 1 year or until relapse.

Medical condition

Acid Reflux

Phase

N/A

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 Jan 1971

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2401&filename=CSR-I-653-B.pdf
Download
https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2401&filename=CSR-I-653-B.pdf
Download
https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2401&filename=CSR-I-653-B.pdf
Download
https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2401&filename=CSR-I-653-B.pdf
Download
CSR-I-653-B.pdf
Download
Trial Results Summaries
Available here

A Randomized, Double-Blind, Parallel-group, Placebo-Controlled comparison of omeprazole 20 mg once daily, omeprazole 10 mg, and placebo in adult patients (18 – 80 years of age) with healed endoscopically-diagnosed gastro esophageal reflux disease (GERD) for 1 year or until relapse.

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2401&filename=CSR-I-653-B.pdf

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2401&filename=CSR-I-653-B.pdf

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2401&filename=CSR-I-653-B.pdf

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2401&filename=CSR-I-653-B.pdf

CSR-I-653-B.pdf

Trial Results Summaries